Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$11.5M Hold
36,128
0.83% 20
2017
Q3
$11.3M Buy
36,128
+7,107
+24% +$2.1M 0.73% 25
2017
Q2
$7.88M Buy
29,021
+7,283
+34% +$1.93M 0.48% 50
2017
Q1
$5.94M Buy
21,738
+9,951
+84% +$2.81M 0.33% 83
2016
Q4
$3.34M Sell
11,787
-9,251
-44% -$2.74M 0.23% 108
2016
Q3
$6.59M Sell
21,038
-19,799
-48% -$5.86M 0.47% 63
2016
Q2
$9.88M Buy
40,837
+29,642
+265% +$7.81M 0.74% 26
2016
Q1
$2.91M Sell
11,195
-1,863
-14% -$492K 0.18% 154
2015
Q4
$4M Sell
13,058
-6,903
-35% -$1.98M 0.24% 115
2015
Q3
$5.83M Sell
19,961
-20,335
-50% -$6.72M 0.15% 164
2015
Q2
$16.3M Buy
40,296
+23,274
+137% +$9.34M 0.35% 82
2015
Q1
$7.19M Sell
17,022
-17,927
-51% -$7.07M 0.2% 132
2014
Q4
$11.9M Buy
34,949
+10,000
+40% +$3.24M 0.36% 86
2014
Q3
$8.25M Buy
24,949
+74
+0.3% +$24.4K 0.22% 139
2014
Q2
$7.84M Buy
24,875
+8,500
+52% +$2.56M 0.23% 132
2014
Q1
$5.01M Buy
+16,375
New +$5.2M 0.17% 167

Other funds holding BIIB

GLG LLC's BIIB Position: Q4 2017 in Review

GLG LLC held its Biogen (BIIB) position steady in Q4 2017 at 36,128 shares worth $11.5M. The position accounts for 0.83% of the portfolio, ranked #20.

GLG LLC first reported a position in BIIB in Q1 2014 and has held it in 16 quarters since. The position peaked at $16.3M in Q2 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • GLG LLC held 36,128 shares of Biogen worth $11.5M as of Q4 2017.
  • GLG LLC left its Biogen share count unchanged in Q4 2017.
  • Biogen made up 0.83% of GLG LLC's portfolio in Q4 2017, its #20 holding.
  • GLG LLC first reported a position in Biogen in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Biogen position peaked at $16.3M in Q2 2015.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.